First in Human, Dose Escalation Study of AN4005

This is a first-in-human study testing a new cancer drug called AN4005 in people with advanced solid tumors or certain types of lymphoma that have not responded to standard treatments. **You may be eligible if...** - You are 18 or older with advanced cancer (solid tumors or lymphoma) that has spread or cannot be removed by surgery - Standard treatments are no longer working or are not available for you - Your heart function is good (ejection fraction above 50%) - Your blood counts, liver, and kidney function meet minimum thresholds - You are willing to provide a tumor tissue sample **You may NOT be eligible if...** - Your cancer has not been confirmed by biopsy - You are pregnant or breastfeeding - Your blood counts, liver, or kidney function are too low - Your general health is too poor to participate (performance status worse than 1) Talk to your doctor to see if this trial is right for you.